pulmonary surfactant的意思

pulmonary surfactant中文翻譯：

肺表面活性物質

相似詞語短語

pulmonary───adj.肺的；有肺的；肺狀的

pulmonary edema───[內科]肺水腫

pulmonary valve───[醫]of pulmonary trunk肺動脈瓣：同valva trunci pulmonalis；[解剖]肺動脈瓣

detersive surfactant───去污表面活性劑

pulmonary circulation───[生理]肺循環；小循環

anionic surfactant───[助劑]陰離子型表面活性劑；陰離子型表面活化劑，陰離子型表面片性劑

foothill pulmonary───山麓肺

pulmonary tuberculosis───[內科]肺結核；n.肺結核

pulmonary hypertension───[生理]肺動脈高血壓；肺動脈血壓過高；[生理]肺動脈高壓癥

雙語使用場景

Objective To study the efficacy of pulmonary surfactant in newborn infants with meconium aspiration syndrome.───目的探討肺表面活性物質治療新生兒胎糞吸入綜合征的有效性及臨床價值。

Objective to evaluate the clinical effect of pulmonary surfactant Curosurf in preventing respiratory distress syndrome of prematures.───目的探討肺泡表面活性物質制劑固爾蘇預防早產兒呼吸窘迫綜合征的臨床療效。

Objective to study the changes of pulmonary surfactant in patients with acute respiratory distress syndrome (ARDS).───目的研究患急性呼吸窘迫綜合征(ARDS)時病人肺泡表面活性物質的變化。

Objective: To explore the clinical effects of pulmonary surfactant on the treatment of neonatal respiratory distress syndrome (NRDS).───目的：探討肺表面活性物質對新生兒呼吸窘迫綜合征（NRDS）的治療效果。

Effect of four mechanical ventilation modes on pulmonary surfactant in early stage after severe smoke inhalation injury in dogs.───機械通氣對嚴重煙霧吸入傷犬早期肺表面活性物質的影響。

Incidence of Complications of the Respiratory Distress Syndrome Following Pulmonary Surfactant Replacement Therapy in Neonates───新生兒呼吸窘迫綜合征應用肺表面活性物質治療后并發癥的對照研究

Isolation and purification of pulmonary surfactant-associated protein A from human amniotic fluid and its bioactivity assessment───入羊水中肺表面活性物質相關蛋白A的提純及生物活性分析

Experimental study of pulmonary surfactant administration to the rabbits'lung grafts───肺表面活性物質對兔供肺作用的實驗研究

Study of the Critical Micelle Concentrations of Pulmonary Surfactant───肺表面活性物質臨界膠團濃度的實驗研究

英語使用場景

AIM To investigate the ruthenium red (RR) staining on the visualizing of ultrastructures of pulmonary surfactant (PS) in injured lungs caused by bleomycin (BLM).

AIM: To evaluate the therapeutic efficacy of intratracheal instillation of porcine pulmonary surfactant (PPS) in rats with lipopolysaccharides (LPS)-induced early-stage ALI in this study.

Objective: To discuss the clinical value of pulmonary surfactant (PS) in the replacement therapy for premature infants with hyaline membrane disease (HMD).

Conclusion Pulmonary surfactant therapy in hyaline membrane disease of newborns can quickly correct the abnormal blood gas, and hence is worthy of being recommended in clinical practice.

Recent studies suggest that GM-CSF correlate with alveolar macrophage function, lung host defense reaction and pulmonary surfactant homeostasis.

Objective To explore the effect of pulmonary surfactant (PS) combined with mechanical ventilation on pulmonary hyaline membrane disease of newborn (HMD) in newborn.